Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 EUR | +0.24% | +3.72% | +19.77% |
May. 15 | Aiforia Wins a Framework Agreement to Provide AI Solutions for Fimlab Laboratories in Finland | CI |
Apr. 24 | Aiforia Signs A Contract with A Veterinary Health Company in the US | CI |
Sales 2024 * | 4.3M 4.63M | Sales 2025 * | 8.1M 8.72M | Capitalization | 121M 130M |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.84M | Net income 2025 * | -10M -10.77M | EV / Sales 2024 * | 24.7 x |
Net cash position 2024 * | 14.2M 15.29M | Net cash position 2025 * | 4.6M 4.95M | EV / Sales 2025 * | 14.3 x |
P/E ratio 2024 * |
-10.2
x | P/E ratio 2025 * |
-11.6
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.08% |
1 day | +0.24% | ||
1 week | +3.72% | ||
Current month | +3.72% | ||
1 month | +6.36% | ||
3 months | +16.11% | ||
6 months | +24.04% | ||
Current year | +19.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 15-08-31 | |
Director of Finance/CFO | 61 | 20-12-31 | |
Toumas Ropponen
CTO | Chief Tech/Sci/R&D Officer | 46 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 13-10-31 | |
Founder | 60 | 13-03-06 | |
Chief Executive Officer | 61 | 15-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 4.18 | +0.24% | 16,765 |
24-06-06 | 4.17 | +1.21% | 32,005 |
24-06-05 | 4.12 | +0.73% | 44,649 |
24-06-04 | 4.09 | -3.99% | 82,404 |
24-06-03 | 4.26 | +5.71% | 181,655 |
Delayed Quote Nasdaq Helsinki, June 07, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.77% | 130M | |
+12.71% | 3,150B | |
+10.98% | 87.56B | |
+8.10% | 80.72B | |
-16.04% | 52.81B | |
+35.76% | 51.91B | |
+30.86% | 46.06B | |
-31.32% | 42.52B | |
+78.94% | 41.62B | |
+2.37% | 28.24B |
- Stock Market
- Equities
- AIFORIA Stock